Atlas Trials

Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)

Clinical trial NCT01936532 · COMPLETED

Trial details

NCT number
NCT01936532
Sponsor
Nantes University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Newly Diagnosed Multiple Myeloma
Start date
2014-11-12
Primary completion
2019-03-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.